Stock Markets Analysis & Opinion

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) reported third-quarter of 2017 results wherein both earnings and sales beat expectations on the back of strong performance of eye-care drug Eylea. ...

Nektar Therapeutics’ (NASDAQ:NKTR) shares increased more than 10% on Nov 7 after reporting better-than-expected third-quarter results with both earnings and sales surpassing...

TEGNA Inc. (NYSE:TGNA) reported impressive financial results in the third quarter of 2017, wherein both the top line and the bottom line outpaced the Zacks Consensus Estimate.Net Income Net income...

Agenus Inc. (NASDAQ:AGEN) incurred loss of 37 cents per share in line with the Zacks Consensus Estimate. The figure came in narrower the year-ago loss of 47 cents.Revenues of $3.4 million missed the...

Shares of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) were down almost 17% on Nov 7 despite receiving FDA approval for a label expansion of its lead drug Auryxia. Lower-than-expected sales of...

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) incurred a loss of $1.34 per share in the third quarter of 2017, wider than the Zacks Consensus Estimate of a loss of $1.23. The figure was also wider...

Short term FTSE Elliott Wave view suggests that decline to 7199.5 ended Primary wave ((4)). Up from there, the rally is unfolding as a zigzag Elliott Wave structure where Intermediate wave (A) ended...

With a major chunk of the earnings releases behind us, the quarter seems to have fared quite well so far. While the number of overall positive surprises has been greater than previous periods, the...

Just as late-market traders on Wall Street left work satisfied they’d sold Snap Inc. (NYSE:SNAP) stock following disappointing Q3 sales results in the app company’s latest report,...

Genpact Limited (NYSE:G) reported third-quarter 2017 non-GAAP earnings of 46 cents per share, which increased 23% on a year-over-year basis. The figure also came ahead of the Zacks Consensus...

Wednesday, November 8, 2017Just as late-market traders on Wall Street left work satisfied they’d sold Snap Inc. (NYSE:SNAP) stock following disappointing Q3 sales results in the app...

It’s been a year since Donald Trump came into power and his administration led to a boom in the stock market, pushing major indices to multiple highs on several occasions. The S&P 500 rose...

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) reported a loss of 14 cents per share in third-quarter 2017, narrower than the Zacks Consensus Estimate of a loss of 21 cents. The company had reported...

Model N, Inc. (NYSE:MODN) reported fiscal fourth-quarter 2017 adjusted loss of 6 cents per share, narrower than the year-ago quarter loss of 28 cents per share. The figure was also narrower than...